Novel mutations in trpm6 gene associated with primary hypomagnesemia with secondary hypocalcemia. Case report

Creative Commons License

Papez J., Starha J., Slaba K., Hubacek J. A., Pecl J., Aulicka S., ...Daha Fazla

Biomedical Papers, cilt.165, sa.4, ss.454-457, 2021 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 165 Sayı: 4
  • Basım Tarihi: 2021
  • Doi Numarası: 10.5507/bp.2021.027
  • Dergi Adı: Biomedical Papers
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, BIOSIS, EMBASE, MEDLINE, Directory of Open Access Journals
  • Sayfa Sayıları: ss.454-457
  • Anahtar Kelimeler: hypomagnesemia, hypocalcemia, transient receptor potential melastatin 6, infantile seizures, FAMILIAL HYPOMAGNESEMIA, TRPM6 MUTATIONS, MAGNESIUM
  • Lokman Hekim Üniversitesi Adresli: Hayır

Özet

© 2021 The Authors; https://creativecommons.org/licenses/by/4.0/.Background. Primary hypomagnesemia with secondary hypocalcemia (HSH) is a rare genetic disorder. Dysfunctional transient receptor potential melastatin 6 causes impaired intestinal absorption of magnesium, leading to low serum levels accompanied by hypocalcemia. Typical signs at initial manifestation are generalized seizures, tetany, and/or muscle spasms. Case report. We present a 5 w/o female manifesting tonic-clonic seizures. Laboratory tests detected severe hypomagnesemia and hypocalcemia. The molecular genetic analysis revealed two novel mutations within the TRPM6 gene c.3308dupC (p.Pro1104Thrfs*28) (p.P1104Tfs*28) and c.3958C>T (p.Gln1302*) (p.Q1302*) and the patient was successfully treated with Mg supplementation. Conclusion. Ion disbalance should be taken into account in the differential diagnosis of infantile seizures. Accurate diagnosis of HSH together with appropriate treatment are crucial to prevent irreversible neurological outcomes.